Instead, some studies have shown that local Immunoglobulin (Ig)A antibodies elicited following LAIV vaccination contribute towards suppression of influenza associated morbidity [4,5,6] and protect against heterologous influenza viral strains [7]. Here, CD79A is linked to influenza.